No Data
No Data
Sector Update: Health Care Stocks Retreat Friday Afternoon
Small-Cap OS Therapies Inks Commercial Manufacture Agreements For Lead Cancer Drug For Rare Type Of Bone Cancer
OS Therapies Says It Signed Manufacturing Deal for Lead Candidate OST-HER2
Wall Street Set to Open Slightly Lower Friday as Retail Sales Slump More Than Expected
OS Therapies Shares Are Trading Higher After the Company Announced Agreements for the Commercial Manufacture of OST-HER2.
OS Therapies Initiates Commercial-ready Manufacturing of OST-HER2 to Support Anticipated Biologics Licensing Authorization (BLA) Filing